<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230808059080N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-14</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Assessment of the function of the telemedicine device</public_title>
      <acronym></acronym>
      <scientific_title>Assessment of the function of the telemedicine device in order to report lead 2 of electrocardiogram, heart rate, body temperature, peripheral pulse rate and the level of blood oxygen</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71907</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Atrial fibrillation and atrial flutter (AF). Condition 2: Ventricular tachycardia (VT). Condition 3: Paroxysmal supraventricular tachycardia (PSVT). Condition 4: Premature ventricular contractions (PVC). Condition 5: Premature atrial contractions (PAC). Condition 6: Atrial tachycardia (AT).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The patients who have at least one of the 6 types of common cardiac arrhythmias diagnosed by the cardiologist and the telemedicine device manufactured in Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences is installed on their body. This device consists of three chest leads, a thermometer in the armpit and a wireless pulse oximeter that is placed on the participant's finger. Intervention 2: Control group: The adults who do not have any of the 6 types of common cardiac arrhythmias and the telemedicine device manufactured in Behbood Samane Hooshmand Teb Company is installed on their body. This device consists of three chest leads, a thermometer in the armpit and a wireless pulse oximeter that is placed on the participant's finger.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data of this study can be shared after de-identifying the individuals.

When:
The access period starts 3 months after the results are published.

To whom:
Data related to this study will be available both to researchers working in academic and scientific centers and to people working in industry.

Conditions:
After sending the request email to the corresponding author, data related to this study will be available both to researchers working in academic and scientific centers and to people working in industry.

Where to obtain:
The corresponding author with email address mt.hedayati@mubabol.ac.ir

How to obtain:
The data related to this study will be available in time up to two months after sending the request email to the corresponding author.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fazel Tarkhan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, Ganjafrooz Avenue, Babol</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647754</zip>
        <telephone>+98 11 3219 7667</telephone>
        <email>medslums@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fazel Tarkhan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, Ganjafrooz Avenue, Babol</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647754</zip>
        <telephone>+98 11 3219 7667</telephone>
        <email>medslums@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 years and over
Refer to the cardiology clinic for check-up or cardiological treatment</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient´s inability to use the telemedicine device
Not to provide consent to participate in the study by the patient</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I48.9</hc_code>
      <hc_code>I47.2</hc_code>
      <hc_code>I47.1</hc_code>
      <hc_code>I49.3</hc_code>
      <hc_code>I49.1</hc_code>
      <hc_code>I47.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified atrial fibrillation and atrial flutter</hc_keyword>
      <hc_keyword>Ventricular tachycardia</hc_keyword>
      <hc_keyword>Supraventricular tachycardia (paroxysmal)</hc_keyword>
      <hc_keyword>Ventricular premature depolarization</hc_keyword>
      <hc_keyword>Atrial premature depolarization</hc_keyword>
      <hc_keyword>Supraventricular tachycardia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The patients who have at least one of the 6 types of common cardiac arrhythmias diagnosed by the cardiologist and the telemedicine device manufactured in Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences is installed on their body. This device consists of three chest leads, a thermometer in the armpit and a wireless pulse oximeter that is placed on the participant's finger.</i_keyword>
      <i_keyword>Control group: The adults who do not have any of the 6 types of common cardiac arrhythmias and the telemedicine device manufactured in Behbood Samane Hooshmand Teb Company is installed on their body. This device consists of three chest leads, a thermometer in the armpit and a wireless pulse oximeter that is placed on the participant's finger.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lead 2 of the electrocardiogram. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.</prim_outcome>
      <prim_outcome>Body temperature. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.</prim_outcome>
      <prim_outcome>The level of blood oxygen. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.</prim_outcome>
      <prim_outcome>Peripheral pulse rate. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: Minute 1, minute 6 and minute 11. Method of measurement: Patient lying supine on a medical bed, after 15 minutes of rest, the medical care device (including three chest leads, an axillary thermometer and a wireless finger pulse oximeter) is installed on his body. The participant will rest again for 5 minutes and then the research primary variables will be measured. Data recording will be initiated at minute 1. With 5-minute intervals, three times of measurement will be carried out on each patient using three SEMS-HIOT devices produced by the Behbood Samane Hooshmand Teb Company affiliated to Technology Incubator of Babol University of Medical Sciences, and one time measurement with a standard device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Acceptance of the device by the patient. Timepoint: At the end of the intervention. Method of measurement: By asking a question about the patient's satisfaction with the device.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-06</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Babol University of Medical Sciences, Ganjafrooz Avenue, Babol Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
